From the Guidelines
Itraconazole for tinea capitis is typically dosed at 5 mg/kg/day for 2-4 weeks, with a maximum daily dose of 100 mg, as recommended by the British Association of Dermatologists' guidelines for the management of tinea capitis 2014 1.
Key Considerations
- The dosage of itraconazole for tinea capitis is based on the patient's weight, with a recommended dose of 5 mg/kg/day for 2-4 weeks 1.
- The treatment duration may vary depending on the causative organism, with some species requiring longer treatment periods 1.
- Itraconazole is generally considered safe and effective for the treatment of tinea capitis, with activity against both Trichophyton and Microsporum species 1.
Important Administration Instructions
- Itraconazole should be taken with food to enhance absorption 1.
- Patients should be monitored for potential drug interactions, as itraconazole is metabolized through the CYP3A4 pathway 1.
- Liver function tests should be considered before and during treatment, especially for extended therapy 1.
Additional Measures
- Adjunctive treatment with antifungal shampoo (such as ketoconazole or selenium sulfide) twice weekly can help reduce spore shedding and prevent transmission 1.
- Children receiving appropriate therapy should be allowed to attend school or nursery, as recommended by the British Association of Dermatologists' guidelines 1.
From the Research
Itraconazole Dosing for Tinea Capitis
- The recommended dosage of itraconazole for tinea capitis is 5 mg/kg/day, as seen in studies 2, 3, 4.
- The duration of treatment can vary from 2-12 weeks, depending on the severity of the disease and the patient's response to treatment 2, 4, 5.
- In some cases, pulse therapy may be used, with each pulse lasting 1 week and separated by a 2-3 week period without treatment 2, 5.
- The dosage can be adjusted based on the patient's weight, with the following guidelines:
- Itraconazole has been shown to be effective in treating tinea capitis caused by various fungal species, including Trichophyton tonsurans, T. violaceum, and Microsporum canis 2, 3, 4.
- The treatment regimen may need to be individualized based on the patient's response to treatment and the severity of the disease 2, 4, 5.